Plewman Patrick's most recent trade in Quest Diagnostics, Inc. was a trade of 5,682 Common Stock done at an average price of $204.9 . Disclosure was reported to the exchange on March 4, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 204.86 per share. | 04 Mar 2026 | 5,682 | 20,880 (0%) | 0% | 204.9 | 1,164,015 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Sale of securities on an exchange or to another person at price $ 206.21 per share. | 04 Mar 2026 | 2,855 | 15,198 (0%) | 0% | 206.2 | 588,730 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 204.86 per share. | 04 Mar 2026 | 2,827 | 18,053 (0%) | 0% | 204.9 | 579,139 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Sale of securities on an exchange or to another person at price $ 207.73 per share. | 02 Mar 2026 | 410 | 15,198 (0%) | 0% | 207.7 | 85,169 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 204.86 per share. | 02 Mar 2026 | 230 | 15,608 (0%) | 0% | 204.9 | 47,118 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2026 | 9,009 | 9,009 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2026 | 1,952 | 17,333 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Sale of securities on an exchange or to another person at price $ 204.83 per share. | 18 Feb 2026 | 958 | 15,838 (0%) | 0% | 204.8 | 196,227 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 206.99 per share. | 18 Feb 2026 | 293 | 16,796 (0%) | 0% | 207.0 | 60,648 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 210.01 per share. | 18 Feb 2026 | 244 | 17,089 (0%) | 0% | 210.0 | 51,242 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 121.81 per share. | 28 Jan 2026 | 5,662 | 21,043 (0%) | 0% | 121.8 | 689,660 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Sale of securities on an exchange or to another person at price $ 204.00 per share. | 28 Jan 2026 | 5,662 | 15,381 (0%) | 0% | 204 | 1,155,048 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2026 | 5,662 | 0 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 183.52 per share. | 28 Jan 2026 | 48 | 15,381 (0%) | 0% | 183.5 | 8,809 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 189.09 per share. | 21 Oct 2025 | 46 | 15,333 (0%) | 0% | 189.1 | 8,698 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Sale of securities on an exchange or to another person at price $ 185.00 per share. | 21 Aug 2025 | 1,975 | 15,269 (0%) | 0% | 185 | 365,375 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 112.17 per share. | 19 Aug 2025 | 4,532 | 21,776 (0%) | 0% | 112.2 | 508,354 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Aug 2025 | 4,532 | 0 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Sale of securities on an exchange or to another person at price $ 183.00 per share. | 19 Aug 2025 | 4,532 | 17,244 (0%) | 0% | 183 | 829,356 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Sale of securities on an exchange or to another person at price $ 180.00 per share. | 15 Aug 2025 | 1,975 | 17,244 (0%) | 0% | 180 | 355,500 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Sale of securities on an exchange or to another person at price $ 175.00 per share. | 06 Aug 2025 | 3,560 | 21,185 (0%) | 0% | 175 | 623,000 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 86.63 per share. | 06 Aug 2025 | 3,560 | 24,745 (0%) | 0% | 86.6 | 308,403 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2025 | 3,560 | 0 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Sale of securities on an exchange or to another person at price $ 175.00 per share. | 06 Aug 2025 | 1,975 | 19,219 (0%) | 0% | 175 | 345,625 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | 21 Jul 2025 | 80 | 21,185 (0%) | 0% | 167.5 | 13,400 | Common Stock | |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | 21 Apr 2025 | 81 | 21,087 (0%) | 0% | 164.4 | 13,318 | Common Stock | |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 166.71 per share. | 26 Mar 2025 | 162 | 20,988 (0%) | 0% | 166.7 | 27,007 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 173.74 per share. | 03 Mar 2025 | 5,674 | 23,430 (0%) | 0% | 173.7 | 985,801 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 173.74 per share. | 03 Mar 2025 | 2,280 | 21,150 (0%) | 0% | 173.7 | 396,127 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 173.74 per share. | 03 Mar 2025 | 106 | 17,756 (0%) | 0% | 173.7 | 18,416 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 171.75 per share. | 26 Feb 2025 | 229 | 17,853 (0%) | 0% | 171.8 | 39,331 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Sale of securities on an exchange or to another person at price $ 169.71 per share. | 19 Feb 2025 | 320 | 18,082 (0%) | 0% | 169.7 | 54,307 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 7,833 | 7,833 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 2,042 | 18,402 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | 29 Jan 2025 | 57 | 16,345 (0%) | 0% | 158.0 | 9,008 | Common Stock | |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | 21 Oct 2024 | 60 | 16,258 (0%) | 0% | 149.4 | 8,962 | Common Stock | |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | 22 Jul 2024 | 60 | 16,162 (0%) | 0% | 147.0 | 8,818 | Common Stock | |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 126.25 per share. | 22 Apr 2024 | 69 | 16,062 (0%) | 0% | 126.2 | 8,711 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 128.11 per share. | 26 Mar 2024 | 114 | 15,981 (0%) | 0% | 128.1 | 14,605 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 126.36 per share. | 28 Feb 2024 | 228 | 16,187 (0%) | 0% | 126.4 | 28,810 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 126.36 per share. | 28 Feb 2024 | 105 | 16,082 (0%) | 0% | 126.4 | 13,268 | Common Stock |
| Quest Diagnostics | Plewman Patrick | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 125.02 per share. | 23 Feb 2024 | 2,388 | 17,284 (0%) | 0% | 125.0 | 298,548 | Common Stock |
| Quest Diagnostics | Plewman Patrick | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.02 per share. | 23 Feb 2024 | 869 | 16,415 (0%) | 0% | 125.0 | 108,642 | Common Stock |
| Quest Diagnostics | Plewman Patrick | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 125.02 per share. | 21 Feb 2024 | 139 | 14,896 (0%) | 0% | 125.0 | 17,378 | Common Stock |
| Quest Diagnostics | Plewman Patrick | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 10,190 | 10,190 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2024 | 2,446 | 15,035 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics | Plewman Patrick | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 129.32 per share. | 31 Jan 2024 | 50 | 12,589 (0%) | 0% | 129.3 | 6,466 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 122.83 per share. | 23 Oct 2023 | 52 | 12,492 (0%) | 0% | 122.8 | 6,387 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 144.59 per share. | 25 Jul 2023 | 44 | 12,397 (0%) | 0% | 144.6 | 6,362 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | 24 Apr 2023 | 44 | 12,319 (0%) | 0% | 143.1 | 6,296 | Common Stock | |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 134.25 per share. | 24 Mar 2023 | 99 | 12,258 (0%) | 0% | 134.3 | 13,291 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 147.86 per share. | 06 Mar 2023 | 2,579 | 13,145 (0%) | 0% | 147.9 | 381,331 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 147.86 per share. | 06 Mar 2023 | 799 | 12,357 (0%) | 0% | 147.9 | 118,140 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 140.69 per share. | 01 Mar 2023 | 90 | 10,566 (0%) | 0% | 140.7 | 12,662 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 7,584 | 7,584 | - | - | Non-Qualifed Stock Option (right to buy) | |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2023 | 1,919 | 10,656 (0%) | 0% | 0 | Common Stock | |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 147.86 per share. | 23 Feb 2023 | 245 | 8,737 (0%) | 0% | 147.9 | 36,226 | Common Stock |
| Quest Diagnostics | Patrick Plewman | SVP for Diagnostic Services | 01 Feb 2023 | 27 | 8,982 (0%) | 0% | 146.7 | 3,962 | Common Stock |